Fig. 7.
Fig. 7. Expression of FLT3 on CD34+ cells (left-hand panel) and coexpression of CD38 and FLT3 on CD34+ BM cells (right-hand panel). For analysis of FLT3 expression, BM MNC cells were stained simultaneously with HPCA-2–FITC and BV10-PE. Cells within region 1 (R1) were considered as CD34+FLT3+ and those in region 2 (R2) were considered as CD34+FLT3−. The right-hand panel shows expression of CD38 (FITC) and FLT3 (PE) on CD34+ cells enriched by 561-Dynal bead enrichment. The cell suspension contained 98.6% CD34+ cells. The quadstat is positioned to indicate the level of PE staining observed with the IgG-PE control.

Expression of FLT3 on CD34+ cells (left-hand panel) and coexpression of CD38 and FLT3 on CD34+ BM cells (right-hand panel). For analysis of FLT3 expression, BM MNC cells were stained simultaneously with HPCA-2–FITC and BV10-PE. Cells within region 1 (R1) were considered as CD34+FLT3+ and those in region 2 (R2) were considered as CD34+FLT3. The right-hand panel shows expression of CD38 (FITC) and FLT3 (PE) on CD34+ cells enriched by 561-Dynal bead enrichment. The cell suspension contained 98.6% CD34+ cells. The quadstat is positioned to indicate the level of PE staining observed with the IgG-PE control.

Close Modal

or Create an Account

Close Modal
Close Modal